TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01526798 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01526798 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00321217 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01483235 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03520140 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT00310336 — Predictive Biomarker (PRD): STAT1 mRNA
Genes: STAT1
Study NCT02190942 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study NCT02255604 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT03808545 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01676766 — Predictive Biomarker (PRD): ABCA4 mRNA
Genes: ABCA4; ABCR
Study NCT01087190 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01991210 — Safety Biomarker (SAF): Vitamin K-dependent protein C
Genes: PROC
Study NCT01563302 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT00353210 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT01979822 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03410550 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03802136 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03087669 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02888886 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02888886 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02681562 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04456296 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00107471 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02760199 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT01250405 — Surrogate Endpoint (SUR): Serum calcium
Study NCT01250405 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03995121 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study NCT00339534 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT01177592 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01783301 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00725127 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01112163 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04002856 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01078571 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00703274 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04254705 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00750906 — Surrogate Endpoint (SUR): Serum potassium
Study NCT05188911 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02364752 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT03695120 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00119054 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00003993 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02148198 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01414855 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01510691 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01510691 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04160897 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04147208 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00439244 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00488176 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00590005 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT04365530 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00203996 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02554487 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02848651 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT01353326 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01456468 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study NCT01458652 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT00081705 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01029626 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04745429 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04745429 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04745429 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01325636 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03971370 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00468689 — Predictive Biomarker (PRD): PGP mRNA
Genes: PGP
Study NCT00468689 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01679860 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT00116467 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01292616 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00375804 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00375804 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01965275 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06421493 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03118258 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03956732 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02905552 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00171730 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study NCT01972373 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01972373 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00869453 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00869453 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT01856413 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04464889 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00320411 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02332850 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT01109043 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02467673 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02467673 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02016053 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04186520 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02573298 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02146898 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00525200 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02951949 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02879669 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01964118 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03394508 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04291560 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02356068 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT04675645 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00001701 — Predictive Biomarker (PRD): SLC11A1 mRNA
Genes: SLC11A1; LSH; NRAMP; NRAMP1
Study NCT00001701 — Predictive Biomarker (PRD): FCGR2A
Genes: CD32; CD32A; IGFR2; CDw32; Fc-gamma-RIIa; FcgammaRIIa
Study NCT00001701 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00001701 — Safety Biomarker (SAF): Interleukin 1
Study NCT00001701 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01804465 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT03669965 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT04435522 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT02142101 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT03728803 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT00335868 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00560859 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03284957 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT03284957 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01691781 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT01691781 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00996645 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02430844 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT02430844 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT02430844 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03637114 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02306005 — Predictive Biomarker (PRD): LCAT mRNA
Genes: LCAT
Study NCT02306005 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02589756 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02589756 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01584102 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02837198 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT01950507 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01950507 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03919214 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03485547 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT03695250 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT02906059 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02906059 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT03920033 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT04388709 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00963547 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00963547 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00673569 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT00673569 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00673569 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04658277 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03063567 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03458494 — Predictive Biomarker (PRD): TCF7L2 mRNA
Genes: TCF7L2; TCF4
Study NCT03458494 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04497688 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01375647 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02885753 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02885753 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04394767 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT02737657 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT05295511 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02283697 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02799511 — Predictive Biomarker (PRD): SLC5A8 mRNA
Genes: SLC5A8; AIT; SMCT; SMCT1
Study NCT03140553 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00754819 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06055647 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04404374 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT00321802 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03414814 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03501316 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01189903 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT03291054 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT04571138 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT04110392 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01569789 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01811160 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00001830 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00001830 — Safety Biomarker (SAF): Th2 cell
Study NCT01221571 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT01903187 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01293721 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03145285 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study NCT01402544 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01168167 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02716571 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02927431 — Predictive Biomarker (PRD): CXCR2 mRNA
Genes: CXCR2; IL8RB
Study NCT04156256 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT02602496 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02602496 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03938389 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT04848545 — Predictive Biomarker (PRD): DDT mRNA
Genes: DDT
Study NCT00856154 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03091634 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03091634 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT03782272 — Predictive Biomarker (PRD): EED mRNA
Genes: EED
Study NCT00025792 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03799055 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT00241410 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT00602225 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02904330 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT02904330 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02312661 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02699645 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00241813 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02911753 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03671460 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00076284 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT00076284 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02164812 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT01103791 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study NCT01038050 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT01038050 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00671892 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT01847794 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01220375 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03548103 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT03548103 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00327678 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02798185 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04488484 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00001878 — Predictive Biomarker (PRD): IGFBP3 mRNA
Genes: IGFBP3; IBP3
Study NCT03075540 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT01652898 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01813097 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT04635943 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02697032 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02660047 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04756024 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT01993342 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01993342 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00988611 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03517956 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT00686192 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00686192 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT02521636 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT01439191 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00628784 — Predictive Biomarker (PRD): HGD mRNA
Genes: HGD; HGO
Study NCT00406445 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03998033 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT03998033 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT02061267 — Safety Biomarker (SAF): Nicotinamide phosphoribosyltransferase
Genes: NAMPT; PBEF; PBEF1
Study NCT01138553 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT01771081 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01771081 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01325415 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT04827160 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02197845 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04013334 — Predictive Biomarker (PRD): DKK3 mRNA
Genes: DKK3; REIC; UNQ258/PRO295
Study NCT03256877 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT00005970 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04168385 — Predictive Biomarker (PRD): ATP8B1 mRNA
Genes: ATP8B1; ATPIC; FIC1; PFIC
Study NCT03430609 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT01581476 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03145142 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study NCT03145142 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03630952 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03630952 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02344602 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02344602 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03932253 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT03932253 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT03932253 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study NCT03932253 — Predictive Biomarker (PRD): MAP2K2 mRNA
Genes: MAP2K2; MEK2; MKK2; PRKMK2
Study NCT03029065 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT03252834 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT03252834 — Predictive Biomarker (PRD): TRPM2 mRNA
Genes: TRPM2; EREG1; KNP3; LTRPC2; TRPC7
Study NCT03252834 — Predictive Biomarker (PRD): TRPA1 mRNA
Genes: TRPA1; ANKTM1
Study NCT03252834 — Predictive Biomarker (PRD): ORAI1 mRNA
Genes: ORAI1; CRACM1; TMEM142A
Study NCT00019968 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04608383 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01913444 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT04731428 — Surrogate Endpoint (SUR): Blood pressure